Tools / Inside Trading Tracker
Inside Trading Tracker
Track insider trading activity at publicly traded companies to understand how executives are trading their shares.
Astrana Health Inc. (ASTH) Insider Trading Activity
Healthcare • Medical Care Facilities • 1,800 employees
Astrana Health, Inc., Inc., a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. The company's physician network consists of primary care physicians, specialist physicians and extenders, and hospitalists. It serves patients, primarily covered by private or public insurance, such as Medicare, Medicaid, and health maintenance organization plans; and non-insured patients. The company was formerly known as Apollo Medical Holdings, Inc. and changed its name to Astrana Health, Inc. in February 2024. Astrana Health, Inc. was incorporated in 1985 and is headquartered in Alhambra, California.
Total Value
-$10,607,384.22
Total Shares
73,195
Average Trade Value
-$558,283.38
Most Active Insider
Allied Physicians Of California, A Professional Medical Corp
Total Activity: $10,551,000
Largest Single Transaction
$10,551,000
by Allied Physicians Of California, A Professional Medical Corp on Jan 17, 2025
30-Day Activity
0 Transactions
Volume: 0 shares
Value: $0
Name
|
Position
|
Date
|
Shares
|
Value
|
Holdings
|
Type
|
---|---|---|---|---|---|---|
Chief Medical Officer
Officer
|
Jan 23, 2025 | 7,210 | $273,692 | 209,291 (-3.4%) | Payment of Exercise Price | |
10% Owner
|
Jan 17, 2025 | 300,000 | $10,551,000 | 6,832,698 (-4.4%) | Sale to Issuer | |
Chief Medical Officer
Officer
|
Jan 1, 2025 | 967 | $30,490 | 215,872 (-0.4%) | Payment of Exercise Price | |
Director
|
Dec 10, 2024 | 5,100 | $219,759 | 14,611 (-34.9%) | Sale to Issuer | |
Chief Accounting Officer
Officer
|
Nov 30, 2024 | 134 | $5,796 | 17,520 (-0.8%) | Payment of Exercise Price | |
Director
|
Nov 22, 2024 | 1,490 | $62,744 | 19,711 (-7.6%) | Payment of Exercise Price | |
Director
|
Nov 22, 2024 | 3,409 | $62,760 | 21,201 (+16.1%) | Exercise/Conversion | |
Director
|
Nov 19, 2024 | 1,515 | $27,891 | 17,364 (+8.7%) | Exercise/Conversion | |
Director
|
Nov 19, 2024 | 681 | $27,873 | 16,683 (-4.1%) | Payment of Exercise Price | |
Executive Chairman
Director, Officer
|
Nov 18, 2024 | 28,046 | $523,058 | 609,905 (+4.6%) | Exercise/Conversion | |
Chief Accounting Officer
Officer
|
Nov 12, 2024 | 636 | $27,291 | 17,654 (-3.6%) | Payment of Exercise Price | |
Director
|
Nov 8, 2024 | 13,333 | $0 | 412,188 (+3.2%) | Grant | |
Director
|
Nov 8, 2024 | 26,667 | $0 | 438,855 (+6.1%) | Grant | |
See Remarks
Officer
|
Nov 8, 2024 | 67,238 | $0 | 216,839 (+31.0%) | Grant | |
Executive Chairman
Director, Officer
|
Nov 8, 2024 | 133,333 | $0 | 581,859 (+22.9%) | Grant | |
COO and CFO
Officer
|
Nov 8, 2024 | 691 | $32,449 | 166,051 (-0.4%) | Payment of Exercise Price | |
Executive Chairman
Director, Officer
|
Nov 8, 2024 | 66,667 | $0 | 448,526 (+14.9%) | Grant | |
COO and CFO
Officer
|
Nov 8, 2024 | 15,510 | $10,000 | 166,742 (+9.3%) | Grant | |
CEO and President
Officer
|
Nov 8, 2024 | 34,386 | $0 | 983,372 (+3.5%) | Grant |